Purchase Order 36C26122P0043
Award Date 10/1/21
Potential Completion Date 12/31/22
Potential Value $502K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Sterling, VA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $1,863,815.56 firm fixed-price definitive contract awarded by the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, for the supply of PYLARIFY (piflufolastat F-18 injection), a radiopharmaceutical used for prostate cancer detection. The contract has an ultimate completion date of December 31, 2025 and was awarded on January 1, 2025 without any set-aside designation. Sofie is a subsidiary of Sofie Biosciences, Inc. and has extensive experience providing...
- The Department of Veterans Affairs (VA) awarded a $1,198,895.04 firm fixed-price purchase order contract to Sofie CO., a small business prime contractor, for the purchase and delivery of the radiopharmaceutical PYLARIFY (Piflufolastat F-18 Injection) over a one-year period. This contract supports the VA's Veterans Health Administration and Veterans Integrated Service Network 5 for radiology services at the DC VA Medical Center. Sofie CO., a subsidiary of Sofie Biosciences, Inc., is an...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a $506,534 firm fixed price purchase order to Sofie CO., doing business as Sofie and a subsidiary of Sofie Biosciences, Inc., to deliver PYLARIFY F18 PIFLUFOLASTAT. The contract will be performed in West Haven, Connecticut over one year, from October 2021 through October 2022. No set aside designation or subcontractors were indicated. The award provides funding for Sofie to deliver...
- Sofie CO., doing business as IBA Molecular, was awarded a delivery order valued at $1,176,442.72 on September 1, 2025, by the Department of Veterans Affairs through Veterans Integrated Service Network 17 (VISN 17) for the supply of PYLARIFY (piflufolastat F-18), a positron emission tomography imaging agent used in prostate cancer detection. This firm fixed-price delivery order, with an ultimate completion date of August 31, 2026, carries no set-aside designation and will be performed in...
- <p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 (VA - VHA) awarded a $290,168.00 firm fixed price purchase order to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc., to provide PYLARIFY (PITFLUFOLAST F18 INJECTION). The place of performance will be in Sterling, Virginia and the period of performance runs from November 18, 2021 through November 17, 2022.</p>
- Sofie Co., a subsidiary of Sofie Biosciences, Inc., was awarded a $453,128 firm fixed price delivery order against the VHA Pharmaceutical Prime Vendor contract to provide Pylarify Piflufolastat F18 radiopharmaceuticals for the Veterans Integrated Service Network 12 region. The one year contract runs from October 2021 through July 2022 and has no set aside designation. The Department of Veterans Affairs Veterans Health Administration will utilize the radiopharmaceuticals in medical imaging...
- The Department of Veterans Affairs Veterans Health Administration awarded a $176,398.24 firm fixed price purchase order to Sofie CO. for the delivery of the radiopharmaceutical PYLARIFY. The contract has a completion date of May 31, 2022 and does not utilize a set-aside designation. Sofie CO. is a for-profit organization that specializes in developing and delivering molecular diagnostics and therapeutics, with extensive experience in PET imaging. The company has received multiple federal...
- This federal contract award is to Sofie CO., a subsidiary of Sofie Biosciences, Inc., for the supply of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used for prostate cancer detection. The $1,947,056.48 Firm Fixed Price contract was awarded by the Veterans Integrated Service Network 2 (VISN 2), a division of the Department of Veterans Affairs (VA). The contract has an ultimate completion date of December 31, 2024. Sofie Biosciences, Inc. is a specialized manufacturer and supplier of...
- This is a federal contract award from the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The $204,375.00 firm-fixed-price purchase order is for the supply of radiopharmaceutical products. The contract does not have a set-aside designation. Sofie CO. is a specialized provider of molecular diagnostics and therapeutics, including radiopharmaceuticals, pharmaceuticals, and related services to various federal agencies such as the VA, Defense Health Agency...
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 15 (VISN 15), a component of the U.S. Department of Veterans Affairs (VA), to Sofie CO. (doing business as IBA Molecular) for the supply of PYLARIFY F-18 DCFPYL, a radiopharmaceutical used for prostate cancer detection. The contract has a ceiling value of $1,172,834.00 and an ultimate completion date of May 31, 2026. Sofie CO. is a for-profit organization specializing in the development,...